9.71
-0.24
(-2.42%)
As of 9:05:29 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 4 |
| Avg. Estimate | 4.38B | 4.64B | 21.02B | 20.07B |
| Low Estimate | 4.29B | 4.52B | 20.32B | 18.72B |
| High Estimate | 4.45B | 4.71B | 21.42B | 20.79B |
| Year Ago Sales | 4.85B | 4.94B | 22.29B | 21.02B |
| Sales Growth (year/est) | -9.53% | -5.96% | -5.69% | -4.56% |
EPS Trend
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MACY.VI | -- | -- | -- | -- |
| S&P 500 | 6.79% | 5.59% | 9.06% | 14.11% |
Upgrades & Downgrades
| Maintains | JP Morgan: Neutral to Neutral | 4/14/2025 |
| Maintains | Telsey Advisory Group: Market Perform to Market Perform | 4/2/2025 |
| Maintains | Citigroup: Neutral to Neutral | 3/7/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 3/7/2025 |
| Maintains | UBS: Sell to Sell | 3/7/2025 |
| Maintains | Telsey Advisory Group: Market Perform to Market Perform | 3/7/2025 |